TNFRSF1B and acute myeloid leukemia: Interestingly, compared with healthy controls, the expression levels of TNFR2 on PB CD4+ T cells, CD4+CD25+ Tregs, as well as CD4+CD25high T cells are considerably increased in ND AML patients, and then the expression levels of TNFR2 decreased markedly when patients achieved remission.